pubmed-article:9744511 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9744511 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
pubmed-article:9744511 | lifeskim:mentions | umls-concept:C0543467 | lld:lifeskim |
pubmed-article:9744511 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
pubmed-article:9744511 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
pubmed-article:9744511 | lifeskim:mentions | umls-concept:C1521808 | lld:lifeskim |
pubmed-article:9744511 | lifeskim:mentions | umls-concept:C1513884 | lld:lifeskim |
pubmed-article:9744511 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:9744511 | lifeskim:mentions | umls-concept:C0456598 | lld:lifeskim |
pubmed-article:9744511 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:9744511 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:9744511 | pubmed:dateCreated | 1998-9-24 | lld:pubmed |
pubmed-article:9744511 | pubmed:abstractText | Thirty-one patients with stage IIIA (N2) non-small-cell lung cancer were randomized to receive radiotherapy alone or chemotherapy with cisplatin and vinblastine followed by surgery. Response rates to induction chemotherapy and radiotherapy were 50% and 53.3% respectively. Complete surgical resection was possible for 62.5% of patients. Median survival times were 16.2 and 18.7 months for radiotherapy alone and chemotherapy-surgery respectively (P = Ns), with no long-term improvement in survival seen with combined-modality treatment. | lld:pubmed |
pubmed-article:9744511 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9744511 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9744511 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9744511 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9744511 | pubmed:language | eng | lld:pubmed |
pubmed-article:9744511 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9744511 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9744511 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9744511 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9744511 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9744511 | pubmed:month | Sep | lld:pubmed |
pubmed-article:9744511 | pubmed:issn | 0007-0920 | lld:pubmed |
pubmed-article:9744511 | pubmed:author | pubmed-author:JamesKK | lld:pubmed |
pubmed-article:9744511 | pubmed:author | pubmed-author:ZehEE | lld:pubmed |
pubmed-article:9744511 | pubmed:author | pubmed-author:OttawayJJ | lld:pubmed |
pubmed-article:9744511 | pubmed:author | pubmed-author:PayneDD | lld:pubmed |
pubmed-article:9744511 | pubmed:author | pubmed-author:CormierYY | lld:pubmed |
pubmed-article:9744511 | pubmed:author | pubmed-author:ShepherdF AFA | lld:pubmed |
pubmed-article:9744511 | pubmed:author | pubmed-author:DeslauriersJJ | lld:pubmed |
pubmed-article:9744511 | pubmed:author | pubmed-author:JohnstonM RMR | lld:pubmed |
pubmed-article:9744511 | pubmed:author | pubmed-author:BurkesRR | lld:pubmed |
pubmed-article:9744511 | pubmed:author | pubmed-author:de BedoyaL... | lld:pubmed |
pubmed-article:9744511 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9744511 | pubmed:volume | 78 | lld:pubmed |
pubmed-article:9744511 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9744511 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9744511 | pubmed:pagination | 683-5 | lld:pubmed |
pubmed-article:9744511 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:9744511 | pubmed:meshHeading | pubmed-meshheading:9744511-... | lld:pubmed |
pubmed-article:9744511 | pubmed:meshHeading | pubmed-meshheading:9744511-... | lld:pubmed |
pubmed-article:9744511 | pubmed:meshHeading | pubmed-meshheading:9744511-... | lld:pubmed |
pubmed-article:9744511 | pubmed:meshHeading | pubmed-meshheading:9744511-... | lld:pubmed |
pubmed-article:9744511 | pubmed:meshHeading | pubmed-meshheading:9744511-... | lld:pubmed |
pubmed-article:9744511 | pubmed:meshHeading | pubmed-meshheading:9744511-... | lld:pubmed |
pubmed-article:9744511 | pubmed:meshHeading | pubmed-meshheading:9744511-... | lld:pubmed |
pubmed-article:9744511 | pubmed:meshHeading | pubmed-meshheading:9744511-... | lld:pubmed |
pubmed-article:9744511 | pubmed:meshHeading | pubmed-meshheading:9744511-... | lld:pubmed |
pubmed-article:9744511 | pubmed:meshHeading | pubmed-meshheading:9744511-... | lld:pubmed |
pubmed-article:9744511 | pubmed:meshHeading | pubmed-meshheading:9744511-... | lld:pubmed |
pubmed-article:9744511 | pubmed:meshHeading | pubmed-meshheading:9744511-... | lld:pubmed |
pubmed-article:9744511 | pubmed:meshHeading | pubmed-meshheading:9744511-... | lld:pubmed |
pubmed-article:9744511 | pubmed:meshHeading | pubmed-meshheading:9744511-... | lld:pubmed |
pubmed-article:9744511 | pubmed:meshHeading | pubmed-meshheading:9744511-... | lld:pubmed |
pubmed-article:9744511 | pubmed:meshHeading | pubmed-meshheading:9744511-... | lld:pubmed |
pubmed-article:9744511 | pubmed:year | 1998 | lld:pubmed |
pubmed-article:9744511 | pubmed:articleTitle | Randomized study of chemotherapy and surgery versus radiotherapy for stage IIIA non-small-cell lung cancer: a National Cancer Institute of Canada Clinical Trials Group Study. | lld:pubmed |
pubmed-article:9744511 | pubmed:affiliation | Interdepartmental Division of Oncology of the University of Toronto, Ontario, Canada. | lld:pubmed |
pubmed-article:9744511 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9744511 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:9744511 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:9744511 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9744511 | lld:pubmed |